Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 55
Filtrar
2.
Epilepsia ; 63(1): e7-e14, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-34778950

RESUMO

A wide phenotypic spectrum of neurological diseases is associated with KCNA1 (Kv1.1) variants. To investigate the molecular basis of such a heterogeneous clinical presentation and identify the possible correlation with in vitro phenotypes, we compared the functional consequences of three heterozygous de novo variants (p.P403S, p.P405L, and p.P405S) in Kv1.1 pore region found in four patients with severe developmental and epileptic encephalopathy (DEE), with those of a de novo variant in the voltage sensor (p.A261T) identified in two patients with mild, carbamazepine-responsive, focal epilepsy. Patch-clamp electrophysiology was used to investigate the functional properties of mutant Kv1.1 subunits, both expressed as homomers and heteromers with wild-type Kv1.1 subunits. KCNA1 pore mutations markedly decreased (p. P405S) or fully suppressed (p. P403S, p. P405L) Kv1.1-mediated currents, exerting loss-of-function (LoF) effects. By contrast, channels carrying the p.A261T variant exhibited a hyperpolarizing shift of the activation process, consistent with a gain-of-function (GoF) effect. The present results unveil a novel correlation between in vitro phenotype (GoF vs LoF) and clinical course (mild vs severe) in KCNA1-related phenotypes. The excellent clinical response to carbamazepine observed in the patients carrying the A261T variant suggests an exquisite sensitivity of KCNA1 GoF to sodium channel inhibition that should be further explored.


Assuntos
Epilepsia , Carbamazepina/uso terapêutico , Epilepsia/tratamento farmacológico , Epilepsia/genética , Humanos , Canal de Potássio Kv1.1/genética , Mutação/genética , Fenótipo
3.
Genes (Basel) ; 12(7)2021 06 24.
Artigo em Inglês | MEDLINE | ID: mdl-34202629

RESUMO

We report on two siblings suffering from different pathogenic conditions, born to consanguineous parents. A multigene panel for brain malformations and microcephaly identified the homozygous splicing variant NM_005886.3:c.1416+1del in the KATNB1 gene in the older sister. On the other hand, exome sequencing revealed the homozygous frameshift variant NM_005245.4:c.9729del in the FAT1 gene in the younger sister, who had a more complex phenotype: in addition to bilateral anophthalmia and heart defects, she showed a right split foot with 4 toes, 5 metacarpals, second toe duplication and preaxial polydactyly on the right hand. These features have been never reported before in patients with pathogenic FAT1 variants and support the role of this gene in the development of limb buds. Notably, each parent was heterozygous for both of these variants, which were ultra-rare and rare, respectively. This study raises awareness about the value of using whole exome/genome sequencing rather than targeted gene panels when testing affected offspring born to consanguineous couples. In this way, exomic data from the parents are also made available for carrier screening, to identify heterozygous pathogenetic and likely pathogenetic variants in genes responsible for other recessive conditions, which may pose a risk for subsequent pregnancies.


Assuntos
Adenosina Trifosfatases/genética , Caderinas/genética , Lisencefalia/genética , Microcefalia/genética , Polidactilia/genética , Polegar/anormalidades , Encéfalo/anormalidades , Encéfalo/diagnóstico por imagem , Encéfalo/patologia , Pré-Escolar , Consanguinidade , Exoma/genética , Feminino , Mutação da Fase de Leitura/genética , Predisposição Genética para Doença , Heterozigoto , Humanos , Lactente , Recém-Nascido , Lisencefalia/diagnóstico por imagem , Lisencefalia/patologia , Microcefalia/diagnóstico por imagem , Microcefalia/patologia , Linhagem , Fenótipo , Polidactilia/diagnóstico por imagem , Polidactilia/patologia , Irmãos , Polegar/diagnóstico por imagem , Polegar/patologia , Sequenciamento do Exoma
5.
Epilepsia ; 60(4): 689-706, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30866059

RESUMO

OBJECTIVE: Copy number variations (CNVs) represent a significant genetic risk for several neurodevelopmental disorders including epilepsy. As knowledge increases, reanalysis of existing data is essential. Reliable estimates of the contribution of CNVs to epilepsies from sizeable populations are not available. METHODS: We assembled a cohort of 1255 patients with preexisting array comparative genomic hybridization or single nucleotide polymorphism array based CNV data. All patients had "epilepsy plus," defined as epilepsy with comorbid features, including intellectual disability, psychiatric symptoms, and other neurological and nonneurological features. CNV classification was conducted using a systematic filtering workflow adapted to epilepsy. RESULTS: Of 1097 patients remaining after genetic data quality control, 120 individuals (10.9%) carried at least one autosomal CNV classified as pathogenic; 19 individuals (1.7%) carried at least one autosomal CNV classified as possibly pathogenic. Eleven patients (1%) carried more than one (possibly) pathogenic CNV. We identified CNVs covering recently reported (HNRNPU) or emerging (RORB) epilepsy genes, and further delineated the phenotype associated with mutations of these genes. Additional novel epilepsy candidate genes emerge from our study. Comparing phenotypic features of pathogenic CNV carriers to those of noncarriers of pathogenic CNVs, we show that patients with nonneurological comorbidities, especially dysmorphism, were more likely to carry pathogenic CNVs (odds ratio = 4.09, confidence interval = 2.51-6.68; P = 2.34 × 10-9 ). Meta-analysis including data from published control groups showed that the presence or absence of epilepsy did not affect the detected frequency of CNVs. SIGNIFICANCE: The use of a specifically adapted workflow enabled identification of pathogenic autosomal CNVs in 10.9% of patients with epilepsy plus, which rose to 12.7% when we also considered possibly pathogenic CNVs. Our data indicate that epilepsy with comorbid features should be considered an indication for patients to be selected for a diagnostic algorithm including CNV detection. Collaborative large-scale CNV reanalysis leads to novel declaration of pathogenicity in unexplained cases and can promote discovery of promising candidate epilepsy genes.


Assuntos
Epilepsia/genética , Comorbidade , Variações do Número de Cópias de DNA , Epilepsia/complicações , Predisposição Genética para Doença , Genótipo , Humanos , Fenótipo
6.
Eur J Hum Genet ; 27(6): 909-918, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-30683929

RESUMO

Periventricular nodular heterotopia (PNH) is a brain malformation in which nodules of neurons are ectopically retained along the lateral ventricles. Genetic causes include FLNA abnormalities (classical X-linked PNH), rare variants in ARFGEF2, DCHS1, ERMARD, FAT4, INTS8, MAP1B, MCPH1, and NEDD4L, as well as several chromosomal abnormalities. We performed array-CGH in 106 patients with different malformations of cortical development (MCD) and looked for common pathways possibly involved in PNH. Forty-two patients, including two parent/proband couples, exhibited PNH associated or not with other brain abnormalities, 44 had polymicrogyria and 20 had rarer MCDs. We found an enrichment of either large rearrangements or cryptic copy number variants (CNVs) in PNH (15/42, 35.7%) vs polymicrogyria (4/44, 9.1%) (i.e., 5.6 times increased risk for PNH of carrying a pathogenic CNV). CNVs in seven genomic regions (2p11.2q12.1, 4p15, 14q11.2q12, 16p13.3, 19q13.33, 20q13.33, 22q11) represented novel, potentially causative, associations with PNH. Through in silico analysis of genes included in imbalances whose breakpoints were clearly detailed, we detected in 9/12 unrelated patients in our series and in 15/24 previously published patients, a significant (P < 0.05) overrepresentation of genes involved in vesicle-mediated transport. Rare genomic imbalances, either small CNVs or large rearrangements, are cumulatively a frequent cause of PNH. Dysregulation of specific cellular mechanisms might play a key pathogenic role in PNH but it remains to be determined whether this is exerted through single genes or the cumulative dosage effect of more genes. Array-CGH should be considered as a first-line diagnostic test in PNH, especially if sporadic and non-classical.


Assuntos
Aberrações Cromossômicas , Variações do Número de Cópias de DNA , Heterogeneidade Genética , Heterotopia Nodular Periventricular/genética , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Heterotopia Nodular Periventricular/diagnóstico por imagem
7.
Am J Med Genet A ; 176(8): 1748-1752, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-30055040

RESUMO

Derangements in voltage-gated potassium channel function are responsible for a range of paroxysmal neurologic disorders. Pathogenic variants in the KCNA1 gene, which encodes the voltage-gated potassium channel Kv1.1, are responsible for Episodic Ataxia Type 1 (EA1). Patients with EA1 have an increased incidence of epilepsy, but KCNA1 variants have not been described in epileptic encephalopathy. Here, we describe four patients with infantile-onset epilepsy and cognitive impairment who harbor de novo KCNA1 variants located within the Kv-specific Pro-Val-Pro (PVP) motif which is essential for channel gating. The first two patients have KCNA1 variants resulting in (p.Pro405Ser) and (p.Pro405Leu), respectively, and a set of identical twins has a variant affecting a nearby residue (p.Pro403Ser). Notably, recurrent de novo variants in the paralogous PVP motif of KCNA2 have previously been shown to abolish channel function and also cause early-onset epileptic encephalopathy. Importantly, this report extends the range of phenotypes associated with KCNA1 variants to include epileptic encephalopathy when the PVP motif is involved.


Assuntos
Disfunção Cognitiva/genética , Epilepsia/genética , Canal de Potássio Kv1.1/genética , Canal de Potássio Kv1.2/genética , Motivos de Aminoácidos/genética , Ataxia/genética , Criança , Pré-Escolar , Disfunção Cognitiva/fisiopatologia , Epilepsia/fisiopatologia , Feminino , Predisposição Genética para Doença , Humanos , Recém-Nascido , Masculino , Mutação , Mioquimia/genética , Fenótipo
8.
Neurol Genet ; 3(6): e206, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29264397

RESUMO

OBJECTIVE: To describe electroclinical features and outcome of 6 patients harboring KCNB1 mutations. METHODS: Clinical, EEG, neuropsychological, and brain MRI data analysis. Targeted next-generation sequencing of a 95 epilepsy gene panel. RESULTS: The mean age at seizure onset was 11 months. The mean follow-up of 11.3 years documented that 4 patients following an infantile phase of frequent seizures became seizure free; the mean age at seizure offset was 4.25 years. Epilepsy phenotypes comprised West syndrome in 2 patients, infantile-onset unspecified generalized epilepsy, myoclonic and photosensitive eyelid myoclonia epilepsy resembling Jeavons syndrome, Lennox-Gastaut syndrome, and focal epilepsy with prolonged occipital or clonic seizures in each and every one. Five patients had developmental delay prior to seizure onset evolving into severe intellectual disability with absent speech and autistic traits in one and stereotypic hand movements with impulse control disorder in another. The patient with Jeavons syndrome evolved into moderate intellectual disability. Mutations were de novo, 4 missense and 2 nonsense, 5 were novel, and 1 resulted from somatic mosaicism. CONCLUSIONS: KCNB1-related manifestations include a spectrum of infantile-onset generalized or focal seizures whose combination leads to early infantile epileptic encephalopathy including West, Lennox-Gastaut, and Jeavons syndromes. Long-term follow-up highlights that following a stormy phase, seizures subside or cease and treatment may be eased or withdrawn. Cognitive and motor functions are almost always delayed prior to seizure onset and evolve into severe, persistent impairment. Thus, KCNB1 mutations are associated with diffuse brain dysfunction combining seizures, motor, and cognitive impairment.

10.
Am J Med Genet A ; 173(4): 1119-1123, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28328131

RESUMO

We describe the clinical and whole genome sequencing (WGS) study of a non-consanguineous Italian family in which two siblings, a boy and a girl, manifesting a severe epileptic encephalopathy (EE) with skeletal abnormalities, carried novel SLC35A3 compound heterozygous mutations. Both siblings exhibited infantile spasms, associated with focal, and tonic vibratory seizures from early infancy. EEG recordings showed a suppression-burst (SB) pattern and multifocal paroxysmal activity in both. In addition both had quadriplegia, acquired microcephaly, and severe intellectual disability. General examination showed distal arthrogryposis predominant in the hands in both siblings and severe left dorso-lumbar convex scoliosis in one. WGS of the siblings-parents quartet identified novel compound heterozygous mutations in SLC35A3 in both children. SLC35A3 encodes the major Golgi uridine diphosphate N-acetylglucosamine transporter. With this study, we add SLC35A3 to the gene list of epilepsies. Neurological symptoms and skeletal abnormalities might result from impaired glycosylation of proteins involved in normal development and function of the central nervous system and skeletal apparatus.


Assuntos
Artrogripose/genética , Deficiência Intelectual/genética , Microcefalia/genética , Mutação , Proteínas de Transporte de Nucleotídeos/genética , Quadriplegia/genética , Espasmos Infantis/genética , Artrogripose/diagnóstico , Artrogripose/patologia , Osso e Ossos/anormalidades , Criança , Eletroencefalografia , Feminino , Expressão Gênica , Glicosilação , Heterozigoto , Humanos , Deficiência Intelectual/diagnóstico , Deficiência Intelectual/patologia , Masculino , Microcefalia/diagnóstico , Microcefalia/patologia , Quadriplegia/diagnóstico , Quadriplegia/patologia , Irmãos , Espasmos Infantis/diagnóstico , Espasmos Infantis/patologia
11.
Hum Mutat ; 38(2): 216-225, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27864847

RESUMO

Targeted resequencing gene panels are used in the diagnostic setting to identify gene defects in epilepsy. We performed targeted resequencing using a 30-genes panel and a 95-genes panel in 349 patients with drug-resistant epilepsies beginning in the first years of life. We identified 71 pathogenic variants, 42 of which novel, in 30 genes, corresponding to 20.3% of the probands. In 66% of mutation positive patients, epilepsy onset occurred before the age of 6 months. The 95-genes panel allowed a genetic diagnosis in 22 (6.3%) patients that would have otherwise been missed using the 30-gene panel. About 50% of mutations were identified in genes coding for sodium and potassium channel components. SCN2A was the most frequently mutated gene followed by SCN1A, KCNQ2, STXBP1, SCN8A, CDKL5, and MECP2. Twenty-nine mutations were identified in 23 additional genes, most of them recently associated with epilepsy. Our data show that panels targeting about 100 genes represent the best cost-effective diagnostic option in pediatric drug-resistant epilepsies. They enable molecular diagnosis of atypical phenotypes, allowing to broaden phenotype-genotype correlations. Molecular diagnosis might influence patients' management and translate into better and specific treatment recommendations in some conditions.


Assuntos
Resistência a Medicamentos/genética , Epilepsia/diagnóstico , Epilepsia/genética , Estudos de Associação Genética , Predisposição Genética para Doença , Mutação , Adolescente , Idade de Início , Alelos , Anticonvulsivantes/farmacologia , Anticonvulsivantes/uso terapêutico , Criança , Pré-Escolar , Biologia Computacional/métodos , Epilepsia/tratamento farmacológico , Feminino , Perfilação da Expressão Gênica , Genótipo , Humanos , Lactente , Recém-Nascido , Imageamento por Ressonância Magnética/métodos , Masculino , Anotação de Sequência Molecular , Fenótipo , Análise de Sequência de DNA
12.
Dev Med Child Neurol ; 58(1): 93-7, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26344814

RESUMO

AIM: Forkhead Box G1 (FOXG1) syndrome is a developmental encephalopathy characterized by postnatal microcephaly, structural brain abnormalities, facial dysmorphisms, severe delay with absent language, defective social interactions, and epilepsy. Abnormal movements in FOXG1 syndrome have often been mentioned but not characterized. METHOD: We clinically assessed and analysed video recordings of eight patients with different mutations or copy number variations affecting the FOXG1 gene and describe the peculiar pattern of the associated movement disorder. RESULTS: The age of the patients in the study ranged from 2 to 17 years old (six females, two males). They had severe epilepsy and exhibited a complex motor disorder including various combinations of dyskinetic and hyperkinetic movements featuring dystonia, chorea, and athetosis. The onset of the movement disorder was apparent within the first year of life, reached its maximum expression within months, and then remained stable. INTERPRETATION: A hyperkinetic-dyskinetic movement disorder emerges as a distinctive feature of the FOXG1-related phenotype. FOXG1 syndrome is as an epileptic-dyskinetic encephalopathy whose clinical presentation bears similarities with ARX- and STXBP1-gene related encephalopathies.


Assuntos
Epilepsia/genética , Fatores de Transcrição Forkhead/genética , Hipercinese/genética , Transtornos dos Movimentos/genética , Proteínas do Tecido Nervoso/genética , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Síndrome
13.
Dev Med Child Neurol ; 57(8): 777-9, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25412988

RESUMO

Drop attacks are sudden, spontaneous falls without loss of consciousness, followed by rapid recovery. Causes in children include severe epilepsies, movement disorders, cataplexy, and psychiatric disorders. We describe two children (a 3-year-old female and a 12-year-old male) with mild neuromotor delay and sudden falls appearing upon starting to walk. Extensive clinical and laboratory investigation was unremarkable. Twenty to 22 months after the onset of falls, both children developed subtle choreiform movements, affecting all four limbs, leading to frequent falls, at times causing traumatic injury. A heterozygous mutation of the TITF1/NKX2-1 gene (14q13) was detected in both patients, allowing the diagnosis of benign hereditary chorea (BHC). Treatment with levodopa attenuated abnormal movements and led to disappearance of drop attacks. A diagnosis of BHC should be considered in young children with recurrent and unexplained drop attacks, especially if associated with neuromotor delay, even in the absence of choreiform movements.


Assuntos
Coreia/genética , Proteínas Nucleares/genética , Síncope/genética , Fatores de Transcrição/genética , Criança , Pré-Escolar , Coreia/complicações , Feminino , Humanos , Masculino , Mutação , Recidiva , Síncope/etiologia , Fator Nuclear 1 de Tireoide
14.
J Health Psychol ; 18(1): 26-37, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22491496

RESUMO

The objective of this article was to examine lifestyle behaviours in eating disorder (ED) patients and healthy controls. A total of 801 ED patients and 727 healthy controls from five European countries completed the questions related to lifestyle behaviours of the Cross-Cultural Questionnaire (CCQ). For children, the ED sample exhibited more solitary activities (rigorously doing homework [p<0.001] and watching TV [p<0.05] and less socializing with friends [p<0.05]) than the healthy control group and this continued in adulthood. There were minimal differences across ED sub-diagnoses and various cross-cultural differences emerged. Reduced social activities may be an important risk and maintaining factor for ED symptomatology.


Assuntos
Transtornos da Alimentação e da Ingestão de Alimentos/psicologia , Relações Interpessoais , Adolescente , Adulto , Estudos de Casos e Controles , Características Culturais , Europa (Continente) , Feminino , Comportamentos Relacionados com a Saúde , Humanos , Masculino , Inquéritos e Questionários , Adulto Jovem
15.
Obes Facts ; 5(3): 408-19, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22797368

RESUMO

OBJECTIVE: The common single nucleotide polymorphism (SNP) rs9939609 in the fat mass and obesity-associated gene (FTO) is associated with obesity. As genetic variants associated with weight regulation might also be implicated in the etiology of eating disorders, we evaluated whether SNP rs9939609 is associated with bulimia nervosa (BN) and anorexia nervosa (AN). METHODS: Association of rs9939609 with BN and AN was assessed in 689 patients with AN, 477 patients with BN, 984 healthy non-population-based controls, and 3,951 population-based controls (KORA-S4). Based on the familial and premorbid occurrence of obesity in patients with BN, we hypothesized an association of the obesity risk A-allele with BN. RESULTS: In accordance with our hypothesis, we observed evidence for association of the rs9939609 A-allele with BN when compared to the non-population-based controls (unadjusted odds ratio (OR) = 1.142, one-sided 95% confidence interval (CI) 1.001-∞; one-sided p = 0.049) and a trend in the population-based controls (OR = 1.124, one-sided 95% CI 0.932-∞; one-sided p = 0.056). Interestingly, compared to both control groups, we further detected a nominal association of the rs9939609 A-allele to AN (OR = 1.181, 95% CI 1.027-1.359, two-sided p = 0.020 or OR = 1.673, 95% CI 1.101-2.541, two-sided p = 0.015,). CONCLUSION: Our data suggest that the obesity-predisposing FTO allele might be relevant in both AN and BN.


Assuntos
Alelos , Anorexia Nervosa/genética , Bulimia Nervosa/genética , Genótipo , Obesidade/genética , Polimorfismo de Nucleotídeo Único , Proteínas/genética , Adolescente , Adulto , Dioxigenase FTO Dependente de alfa-Cetoglutarato , Criança , Intervalos de Confiança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Risco , Adulto Jovem
17.
Arch Neurol ; 68(1): 99-106, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21220680

RESUMO

OBJECTIVE: To reexamine the association between the neuronal sortilin-related receptor gene (SORL1) and Alzheimer disease (AD). DESIGN: Comprehensive and unbiased meta-analysis of all published and unpublished data from case-control studies for the SORL1 single-nucleotide polymorphisms (SNPs) that had been repeatedly assessed across studies. SETTING: Academic research institutions in the United States, the Netherlands, Canada, Belgium, the United Kingdom, Singapore, Japan, Sweden, Germany, France, and Italy. PARTICIPANTS: All published white and Asian case-control data sets, which included a total of 12,464 cases and 17,929 controls. MAIN OUTCOME MEASURES: Alzheimer disease according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) and the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (now known as the Alzheimer's Association). RESULTS: In the white data sets, several markers were associated with AD after correction for multiple testing, including previously reported SNPs 8, 9, and 10 (P < .001). In addition, the C-G-C haplotype at SNPs 8 through 10 was associated with AD risk (P < .001). In the combined Asian data sets, SNPs 19 and 23 through 25 were associated with AD risk (P < .001). The disease-associated alleles at SNPs 8, 9, and 10 (120,873,131-120,886,175 base pairs [bp]; C-G-C alleles), at SNP 19 (120,953,300 bp; G allele), and at SNPs 24 through 25 (120,988,611 bp; T and C alleles) were the same previously reported alleles. The SNPs 4 through 5, 8 through 10, 12, and 19 through 25 belong to distinct linkage disequilibrium blocks. The same alleles at SNPs 8 through 10 (C-G-C), 19 (G), and 24 and 25 (T and C) have also been associated with AD endophenotypes, including white matter hyperintensities and hippocampal atrophy on magnetic resonance imaging, cerebrospinal fluid measures of amyloid ß-peptide 42, and full-length SORL1 expression in the human brain. CONCLUSION: This comprehensive meta-analysis provides confirmatory evidence that multiple SORL1 variants in distinct linkage disequilibrium blocks are associated with AD.


Assuntos
Doença de Alzheimer/genética , Variação Genética/genética , Proteínas Relacionadas a Receptor de LDL/genética , Proteínas de Membrana Transportadoras/genética , Proteínas do Tecido Nervoso/genética , Alelos , Doença de Alzheimer/epidemiologia , Doença de Alzheimer/etiologia , Estudos de Casos e Controles , Humanos , Polimorfismo de Nucleotídeo Único/genética
18.
Clin Psychol Psychother ; 18(6): 535-52, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-20886660

RESUMO

OBJECTIVE: To explore the psychometric properties of the Cross-Cultural Questionnaire (CCQ), a new self-report tool for assessing factors of risk and maintenance for eating disorders (ED). METHOD: Data was collected during a multi-centre case-control study. The sample included 854 ED patients and 784 healthy participants from the UK, Spain, Austria, Slovenia and Italy. Exploratory factor analyses examined the factor structure of each section of the CCQ, and Cronbach's alpha coefficients valued the internal consistency of each derived scale score. Logistic regression and receiver operating characteristic (ROC) curve procedure assessed the screening accuracy and predictive validity of the empirical factors. RESULTS: Based on a total of 127 items, nine dimensions emerged, with satisfactory internal consistency and high congruence between countries. CCQ scores demonstrated satisfactory accuracy for discriminating between ED cases and controls (area under the ROC curve = 0.88). Most of the items achieved discriminative accuracy. CONCLUSIONS: This study offers preliminary evidence that the CCQ, available in five languages, is a useful and valid tool to assess factors of risk and maintenance for EDs.


Assuntos
Comparação Transcultural , Transtornos da Alimentação e da Ingestão de Alimentos/epidemiologia , Transtornos da Alimentação e da Ingestão de Alimentos/psicologia , Inquéritos e Questionários , Adulto , Áustria/epidemiologia , Imagem Corporal , Estudos de Casos e Controles , Estudos de Coortes , Europa (Continente)/epidemiologia , Análise Fatorial , Feminino , Humanos , Itália/epidemiologia , Londres/epidemiologia , Masculino , Psicometria , Curva ROC , Reprodutibilidade dos Testes , Fatores de Risco , Eslovênia/epidemiologia , Espanha/epidemiologia , Adulto Jovem
19.
Neurobiol Aging ; 32(2): 210-22, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19297055

RESUMO

A growing body of evidence implicates low membrane cholesterol in the pathogenesis of Alzheimer's disease (AD). Here we show that Aß42 soluble oligomers accumulate more slowly and in reduced amount at the plasma membranes of PS-1L392V and APPV717I fibroblasts from familial AD (FAD) patients enriched in cholesterol content than at the counterpart membranes. The Aß42-induced production of reactive oxygen species (ROS) and the increase in membrane lipoperoxidation were also prevented by high membrane cholesterol, thus resulting in a higher resistance to amyloid toxicity with respect to control fibroblasts. On the other hand, the recruitment of amyloid assemblies to the plasma membrane of cholesterol-depleted fibroblasts was significantly increased, thus triggering an earlier and sharper production of ROS and a higher membrane oxidative injury. These results identify membrane cholesterol as being key to Aß42 oligomer accumulation at the cell surfaces and to the following Aß42-induced cell death in AD neurons.


Assuntos
Peptídeos beta-Amiloides/metabolismo , Membrana Celular/metabolismo , Colesterol/metabolismo , Fibroblastos/patologia , Estresse Oxidativo/efeitos dos fármacos , Adulto , Idoso , Doença de Alzheimer/genética , Doença de Alzheimer/patologia , Peptídeos beta-Amiloides/farmacologia , Precursor de Proteína beta-Amiloide/genética , Membrana Celular/efeitos dos fármacos , Células Cultivadas , Feminino , Fibroblastos/metabolismo , Fibroblastos/ultraestrutura , Humanos , Peróxidos Lipídicos/metabolismo , Masculino , Pessoa de Meia-Idade , Mutação/genética , Espécies Reativas de Oxigênio/metabolismo , Fatores de Tempo
20.
Psychiatr Genet ; 20(6): 282-8, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20440229

RESUMO

OBJECTIVE: Glucocorticoids (GCs) are involved in the control of eating behaviors, and it has been proposed that GCs and their receptors (GR) could play a significant role in the pathophysiology of eating disorders (EDs) and obesity. We studied whether genetic variants, such as N363S (rs56149945), exon 9-ß (rs6198), ER22/23EK (rs6189-6190), and the intronic BclI restriction site (rs41423247) polymorphisms in the GR gene, could be considered as risk factors for the development of EDs and obesity in Italian patients. METHODS: We investigated the distribution of these single nucleotide polymorphisms in 572 Italian patients: 118 patients with anorexia nervosa, 108 patients with bulimia nervosa, 62 patient with binge eating disorder, 177 obese non-binge eating disorder patients, and 107 unrelated, normal, age-matched controls. In addition, we analyzed their possible effects on body mass index and in relation to different psychopathological features. RESULTS: A significant association between the single nucleotide polymorphism rs56149945 (N363S) and a higher body mass index was identified, even after adjusting for age, sex, and diagnosis, independently of the eating psychopathology. Moreover, the rs6198 polymorphism was associated to binge eating symptoms, whereas no significant association between the different GR polymorphisms and the other ED diagnoses was observed. CONCLUSION: Our results suggest the possible role of the GC system in the genetics of eating psychopathology, weight control, and energy balance in ED and obese patients.


Assuntos
Transtornos da Alimentação e da Ingestão de Alimentos/genética , Obesidade/genética , Polimorfismo de Nucleotídeo Único/genética , Receptores de Glucocorticoides/genética , Adolescente , Alelos , Índice de Massa Corporal , Éxons/genética , Feminino , Genótipo , Humanos , Itália , Masculino , Análise Multivariada , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...